Products – DIA-COVID®

Antigen COVID-19/Flu A+B

COVID-19 and Influenza A+B Antigen Combination Rapid Test supports medical staff in diagnosing SARS-CoV-2, Influenza A or B infections in patients with clinical symptoms.

The number of COVID-19 cases is increasing again, transmission often also from people without symptoms.
Although in some situations regular analysis by the external laboratory PCR (as prescribed) can measure the virus in certain cases (return trip, contact with infected persons), the PCR is not carried out regularly for all persons and also lasts (until the result is received) usually one to several days.

This method of antigen determination can and should only be used in close consultation with medical experts, e.g. external or company doctors, and together with the already existing officially compliant containment strategy can be carried out in addition in your organization.
In order to measure a current COVID-19 infection in a person within 15 minutes, both the antigen from SARS-CoV-2 and influenza A or B can be detected with the rapid test.
Simple collection of nasal swab, result visible after only 15 minutes.
DIA-COVID® Antigen Combo

Safety during the pandemic

All important components (Test cassette, processing tube, sampling swabs, extraction buffer, dripper) are contained in each individual package and the examination can only be carried out directly by medical specialists in a few minutes. In addition to the existing European approval (CE), the product was tested directly at the Essen University Hospital with blood samples from patients with Covid-19.

In coordination with the medical team of the organization, the antigen status can be measured very quickly as part of the Corona security strategy in order not to replace the very important other methods and processes (PCR, distancing, masks, home office) but to supplement and improve them in a meaningful way and faster to be able to react.

Virology

Other products